NMR studies of V3 peptide complexes with antibodies suggest a mechanism for HIV-1 co-receptor selectivity

被引：0
作者：
Sharon, M [1 ]
Rosen, O [1 ]
Anglister, J [1 ]
机构：
[1] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel
来源：
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT | 2005年 / 8卷 / 05期
关键词：
HIV-1; co-receptor; gp120; NMR of antibodies; V3;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The third variable region (V3) of the HIV-1 envelope glycoprotein gp120 is involved in gp120 binding to the chemokine receptors CCR5 and CXCR4, which serve as co-receptors in HIV-1 infection. The sequence of V3 determines whether the virus binds to CCR5 and infects predominantly macrophages (R5 virus) or to CXCR4 and infects mostly T-cells (X4 virus). This review summarizes structural information for V3 peptides in complex with HIV-1 neutralizing antibodies. Nuclear magnetic resonance studies of the V3 peptides led to the proposal of a mechanism for co-receptor selectivity. Experiments to further explore this mechanism and potential applications of V3 structural information are discussed.
引用
收藏
页码：601 / 612
页数：12
相关论文
共 50 条
[41]   Sequence variation and consensus sequence of V3 loop on HIV-1 gp120 [J].
Tian, HJ ;
Lan, CH ;
Chen, YH .
IMMUNOLOGY LETTERS, 2002, 83 (03) :231-233
[42]   Structural characteristics and biological functions of the HIV-1 gp120 V3 region [J].
Tian, HJ ;
Lan, CH ;
Jiang, SB ;
Chen, YH .
PROGRESS IN NATURAL SCIENCE-MATERIALS INTERNATIONAL, 2002, 12 (11) :808-812
[43]   Evaluation of the automatic editing tool RECall for HIV-1 pol and V3 loop sequences [J].
Vinken, Lore ;
Megens, Sarah ;
Schrooten, Yoeri ;
Vandamme, Anne-Mieke ;
Van Laethem, Kristel .
JOURNAL OF VIROLOGICAL METHODS, 2013, 193 (01) :135-139
[44]   Envelope diversity, characteristics of V3 region and predicted co-receptor usage of human immunodeficiency viruses infecting north indians [J].
Raiees Andrabi ;
Rajesh Kumar ;
Manju Bala ;
Ambili Nair ;
Prakash SS ;
Vandana Kushwaha ;
Kalpana Luthra .
Journal of Microbiology, 2012, 50 :869-873
[45]   Envelope Diversity, Characteristics of V3 Region and Predicted Co-Receptor Usage of Human Immunodeficiency Viruses Infecting North Indians [J].
Andrabi, Raiees ;
Kumar, Rajesh ;
Bala, Manju ;
Nair, Ambili ;
Prakash, S. S. ;
Kushwaha, Vandana ;
Luthra, Kalpana .
JOURNAL OF MICROBIOLOGY, 2012, 50 (05) :869-873
[46]   A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site [J].
Li, Liuzhe ;
Wang, Xiao-Hong ;
Williams, Constance ;
Volsky, Barbara ;
Steczko, Olivia ;
Seaman, Michael S. ;
Luthra, Kalpana ;
Nyambi, Phillipe ;
Nadas, Arthur ;
Giudicelli, Veronique ;
Lefranc, Marie-Paule ;
Zolla-Pazner, Susan ;
Gorny, Miroslaw K. .
MOLECULAR IMMUNOLOGY, 2015, 66 (02) :364-374
[47]   Quantifying the relationship between HIV-1 susceptibility to CCR5 antagonists and virus affinity for antagonist-occupied co-receptor [J].
Buontempo, Peter J. ;
Wojcik, Lisa ;
Buontempo, Catherine A. ;
Ogert, Robert A. ;
Strizki, Julie M. ;
Howe, John A. ;
Ralston, Robert .
VIROLOGY, 2009, 395 (02) :268-279
[48]   Improved guanide compounds which bind the CXCR4 co-receptor and inhibit HIV-1 infection [J].
Wilkinson, Royce A. ;
Pincus, Seth H. ;
Song, Kejing ;
Shepard, Joyce B. ;
Weaver, Alan J., Jr. ;
Labib, Mohamed E. ;
Teintze, Martin .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (07) :2197-2201
[49]   THE COMPLETE CONSENSUS V3 LOOP PEPTIDE OF THE ENVELOPE PROTEIN GP120 OF HIV-1 SHOWS PRONOUNCED HELICAL CHARACTER IN SOLUTION [J].
VRANKEN, WF ;
BUDESINSKY, M ;
FANT, F ;
BOULEZ, K ;
BORREMANS, FAM .
FEBS LETTERS, 1995, 374 (01) :117-121
[50]   SINGLE PEPTIDE AND ANTIIDIOTYPE BASED IMMUNIZATIONS CAN BROADEN THE ANTIBODY-RESPONSE AGAINST THE VARIABLE V3 DOMAIN OF HIV-1 IN MICE [J].
BOUDET, F ;
KELLER, H ;
KIENY, MP ;
THEZE, J .
MOLECULAR IMMUNOLOGY, 1995, 32 (07) :449-457
12345